Ritalinic acid
Ritalinic acid (Ritalinate) is the main inactive urinary metabolite of Methylphenidate. Methylphenidate has the potential for attention-deficit hyperactivity disorder and narcolepsy research[1].
Product Specifications
CAS Number
[19395-41-6]
Product Name Alternative
Ritalinate
UNSPSC
12352005
Hazard Statement
H319
Target
Drug Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/ritalinic-acid.html
Purity
99.94
Solubility
H2O : 4.03 mg/mL (ultrasonic; adjust pH to 12 with 1 M NaOH)
Smiles
C2=C(C(C1CCCCN1)C(O)=O)C=CC=C2
Molecular Formula
C13H17NO2
Molecular Weight
219.28
Precautions
H319
References & Citations
[1]Ricardo Jorge Dinis-Oliveira, et al. Metabolomics of Methylphenidate and Ethylphenidate: Implications in Pharmacological and Toxicological Effects. Eur J Drug Metab Pharmacokinet. 2017 Feb;42 (1) :11-16.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
